Pfizer (PFE) : Dnb Asset Management As scooped up 388,300 additional shares in Pfizer during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 11, 2016. The investment management firm now holds a total of 2,526,392 shares of Pfizer which is valued at $82,107,740.Pfizer makes up approximately 1.69% of Dnb Asset Management As’s portfolio.
Pfizer closed down -0.15 points or -0.46% at $32.5 with 3,52,74,322 shares getting traded on Friday. Post opening the session at $32.65, the shares hit an intraday low of $32.3 and an intraday high of $32.785 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
Other Hedge Funds, Including , Lynch Associatesin reduced its stake in PFE by selling 1,372 shares or 0.89% in the most recent quarter. The Hedge Fund company now holds 152,598 shares of PFE which is valued at $4,959,435. Pfizer makes up approx 2.33% of Lynch Associatesin’s portfolio.Triangle Securities Wealth Management boosted its stake in PFE in the latest quarter, The investment management firm added 452 additional shares and now holds a total of 18,845 shares of Pfizer which is valued at $600,967. Pfizer makes up approx 0.39% of Triangle Securities Wealth Management’s portfolio.Baystate Wealth Management boosted its stake in PFE in the latest quarter, The investment management firm added 17 additional shares and now holds a total of 28,155 shares of Pfizer which is valued at $897,863. Pfizer makes up approx 0.20% of Baystate Wealth Management’s portfolio.Thompson Rubinstein Investment Management Inc Or boosted its stake in PFE in the latest quarter, The investment management firm added 38,807 additional shares and now holds a total of 99,112 shares of Pfizer which is valued at $3,160,682. Pfizer makes up approx 1.30% of Thompson Rubinstein Investment Management Inc Or’s portfolio.First National Bank Of Mount Dora Trust Investment Services reduced its stake in PFE by selling 5,213 shares or 10.21% in the most recent quarter. The Hedge Fund company now holds 45,842 shares of PFE which is valued at $1,461,901. Pfizer makes up approx 0.87% of First National Bank Of Mount Dora Trust Investment Services’s portfolio.
On the company’s financial health, Pfizer reported $0.53 EPS for the quarter, beating the analyst consensus estimate by $ 0.17 according to the earnings call on Feb 2, 2016. Analyst had a consensus of $0.36. The company had revenue of $14047.00 million for the quarter, compared to analysts expectations of $13595.19 million. The company’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.54 EPS.
Many Wall Street Analysts have commented on Pfizer. JP Morgan Resumed Pfizer on Apr 7, 2016 to “Overweight”, Price Target of the shares are set at $38.Morgan Stanley Resumed Pfizer on Apr 7, 2016 to “Equal-Weight”, Price Target of the shares are set at $35.
Pfizer Inc. is a global biopharmaceutical company. The Company is engaged in discovering developing and manufacturing of healthcare products. Its products include Lyrica the Prevnar family of products Enbrel Celebrex Lipitor Viagra Zyvox Sutent EpiPen Toviaz Tygacil Rapamune Xalkori Inlyta Norvasc BeneFIX Genotropin and Enbrel among others. It operates in three segments: Global Innovative Pharmaceutical segment (GIP) Global Vaccines Oncology and Consumer Healthcare segment (VOC) and Global Established Pharmaceutical segment (GEP). GIP is focused on developing registering and commercializing medications in therapeutic areas such as inflammation cardiovascular/metabolic neuroscience and pain rare diseases and women’s/men’s health. VOC focuses on the development and commercialization of vaccines and products for oncology and consumer healthcare. GEP includes its sterile injectable products and bio similar development portfolio. Its subsidiary is Hospira Inc.